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Transducin is a GTP-binding protein which mediates the light activation signal from photolyzed rhodopsin 
to cGMP phosphodiesterase and is pivotal in the visual excitation process. Biochemical studies suggest that 
the T, subunit of transducin is composed of three functional domains, one for rhodopsin/Tg, interaction, 
another for guanine nucleotide binding, and a third for the activation of phosphodiesterase. The integration 
of the primary sequence of T, along with secondary structure, hydropathy and folding topology predictions, 
and a comparison with homologous proteins have led to the construction of a three-dimensional model of 
the T, subunit. A molecular mechanism which underlies the coupling action of T, is suggested on the basis 
of this model. 
Transducin; GTP-binding protein; Protein folding; Visual signal transduction; Retinal cyclic GMP cascade; 
Enzyme mechanism 
1. INTRODUCTION 
The primary event in visual excitation is the 
photolysis of rhodopsin. This triggers a series of 
biochemical events which lead to the transient 
hyperpolarization of the rod cells by reducing the 
inward Na+ current across the plasma membrane 
(review [l]). This signal transduction process has 
been shown to involve the activation of a cGMP 
cascade. A GTP-binding protein called transducin 
is required for transmitting the light signal from 
photolyzed rhodopsin to the cGMP phosphodies- 
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terase (PDE) [2]. Transducin contains three poly- 
peptide chains which have been purified into two 
subunits (T,, M, 40000, and Tp?, M, 37000 and 
8000) [3]. A photolyzed rhodopsin catalyzes the ex- 
change of GTP for the bound GDP in hundreds of 
transducin molecules. The incorporation of GTP 
into T, leads to the dissociation of transducin 
subunits from rhodopsin. The T,-GTP complex 
then activates PDE which hydrolyzes thousands of 
cGMP to 5 ’ -GMP. As a signal transducer, the T, 
subunit must contain sites for interaction with 
rhodopsin, the TB,, subunit, guanine nucleotides, 
and the PDE. An understanding of the interactions 
between these functional sites is essential for the 
elucidation of the transduction mechanism. 
Biochemical data on the structural and func- 
tional relationships of the T, molecule are now 
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available and include the primary sequence 
elucidated via molecular cloning [4-71, peptide 
mapping [8], and functional domain analysis 
through chemical modification [9,10]. Moreover, 
the homology between the GTP-binding site of T, 
and those of the G-proteins coupled to adenylate 
cyclase, elongation factor Tu (EF-Tu) and the ras 
p21 protein has been identified [4-7,111. Recently, 
the tertiary structure of the GTP-binding domain 
of EF-Tu was solved to a resolution of 2.7 A by X- 
ray crystallography [12,13] and has served as a 
model for the ras gene product [14] and for the 
partial folding of a consensus GTP-binding site 
[15]. We have extended these studies by integrating 
all the known biochemical characteristics of T,, 
and proposing a three-dimensional model. A 
molecular switching mechanism of TcY which con- 
trols the visual signal transduction process is also 
described. 
2. THE MODEL 
First, the secondary structure and hydropathy of 
the molecule were predicted from the primary se- 
quence and served as a foundation for the folding 
efforts. Then, analysis of limited proteolysis and 
chemical modification studies have allowed us to 
assign all the functional sites of T, on a linear tryp- 
tic peptide map. Next, the probable folding pattern 
for each of the domains was determined. The 
folding topology for T, was established by com- 
parison to other proteins which are either similar in 
secondary structure composition and arrangement 
or in their substrate binding sites, and whose ter- 
tiary structures have been solved by X-ray diffrac- 
tion. This analysis has led to a general picture of 
the protein. Finally, all known biochemical data 
on T, have been examined to verify the validity of 
the proposed structure. 
2.1. Primary and secondary structure, hydropathy 
and functional domains 
The T, molecule is composed of 350 amino acid 
residues with a calculated molecular mass of 
39945 Da. Information concerning the secondary 
structure of the T, peptide was obtained using the 
algorithms of Chou and Fasman [16] and Garnier 
et al. [17]. The algorithm of Kyte and Doolittle 
[ 181 was used to generate the hydropathy profile of 
the molecule (fig.lA). Fig.lB shows the peptide 
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map of T,. Trypsin treatment first cleaves off a 
2 kDa peptide (Try-l at Lysrs) from the amino- 
terminus. A second cleavage removes a 5 kDa pep- 
tide (Try-2 at Arg3re) from the carboxyl-terminus 
and generates a transient 33 kDa fragment which is 
finally cleaved to a 21 and 12 kDa fragment (Try-3 
at Arg240). The removal of the 2 kDa amino- 
terminal fragment disrupts the interaction of T,, 
with rhodopsin and Tp,. The middle 33 kDa frag- 
ment containing the bound Gpp(NH)p remained 
capable of activating PDE [8]. Chemical modifica- 
tion has been used to identify a number of func- 
tional sites on the linear peptide map. 
Modification of a lysine residue on the 21 kDa 
fragment leads to the inhibition of PDE activation 
[lo]. On the other hand, modification of a 
sulfhydryl group on the 12 kDa peptide affects the 
rhodopsin-transducin interaction [9]. Cholera tox- 
in, which ADP-ribosylates the 21 kDa fragment 
(CT at Argr74), blocks the hydrolysis of the bound 
GTP [19], whereas pertussis toxin, which ADP- 
ribosylates the 5 kDa carboxyl-terminal fragment 
(PT at Cys347), inhibits the transducin-rhodopsin 
interaction thus preventing guanine nucleotide ex- 
change [20]. This information indicates that the T,, 
molecule is composed of three functional domains 
(fig.lB). Domain 1 (Dl) includes mainly the 
12 kDa and part of the 21 kDa fragment and con- 
sists of the nucleotide-binding site; domain 2 (D2) 
which is contained entirely within the 21 kDa frag- 
ment is responsible for the interaction with and ac- 
tivation of PDE; and domain 3 (D3), consisting of 
the amino- and carboxyl-terminal (2 and 5 kDa) 
peptides, binds with T#, and rhodopsin. In 
general, the link between functional domains is 
composed of extremely flexible regions which act 
as movable hinges and allow a conformational 
change in one domain to be conveyed to another 
domain. A careful inspection of the primary se- 
quence of T,, reveals two such regions 
(Glyr98-G1y199 and Glyzs8-Pro289-Asn29& both of 
which are located between the proposed functional 
domains of the T, molecule (fig.lB, black 
triangles). 
The primary sequence of T, was compared to 
other GTP-binding proteins such as the elongation 
factor Tu (EF-Tu). T, contains four regions that 
exhibit significant sequence homology at the 
nucleotide-binding site. The site is separated into 
two regions on the linear peptide map (the shaded 
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Fig.1. Secondary structure, hydropathy plot, peptide map, and P-sheet topology of T,,. (A) The predicted secondary 
structure of T, is indicated in a schematic manner. Primary sequence information is from 14-71. The coils, the zig-zags 
and the flat segments represent regions of cu-helices, P-strands, and random coils and &turns, respectively. The 
hydropathy plot of T, is shown. The positive values indicate hydrophobic regions and the negative values indicate 
hydrophilic regions. (B) The linear peptide map of T,?. (C) Schematic diagram of the topology of the P-pleated sheets 
for the two major functional domains of T,. The arrows correspond to individual P-strands. Comparison of the 
topology of the proposed nucleotide-binding domain of T, with that of EF-Tu and the PDE site of T,, with Cu,Zn 
superoxide dismutase. In T,, the arrows, from left to right, represent p-strands N, M, L, A, K, J in the nucleotide- 
binding site and P-strands B, C, D, G, F, E, H, I in the PDE site as shown in fig.2. 
area in fig. 1 B). The guanine ring-binding region is 
located towards the carboxyl-terminus and the 
regions responsible for phosphate binding and for 
hydrolytic activity are located close to the amino- 
terminus. Between these two segments is a variable 
region which represents the effector-binding site, 
i.e. the PDE-binding domain for T,. 
2.2. A model for the tertiary structure 
The possible folding pattern for each domain of 
T, was determined separately and then these struc- 
tures were combined to build a complete three- 
dimensional model. The most reasonable folding 
topology for each domain was examined by com- 
paring T, with other homologous proteins that 
contain a similar arrangement in the primary or 
secondary structure and whose tertiary structures 
have been elucidated by X-ray crystallography. 
The similarity between T, and EF-Tu suggests that 
the guanine nucleotide-binding domain of T, con- 
sists of 157 residues and has the parallel a/P 
doubly wound structure. We propose that the 
GTP-binding site of T,, like that of EF-Tu, has a 
P-sheet topology of (+ 2, - 1, - 2x, - lx, - lx) ac- 
cording to the nomenclature of Richardson [21,22] 
and is shown in fig.lC. 
An examination of the secondary structure 
within the PDE domain of T, shows several ,& 
strands in tandem, separated by turns and coils. 
Such an arrangement strongly suggests an anti- 
parallel&sheet topology. We propose that this do- 
main, which consists of eight P-strands, forms the 
‘Greek key’ barrel structure as described by 
Richardson [21,22]. This is the most common 
subgroup of anti-parallel p-structures and is found 
in enzymes such as Cu,Zn superoxide dismutase 
and prealbumin. This domain consists of 127 
residues and is contained entirely within the 
21 kDa tryptic fragment (Leur9-Arg204). A 
(-1,-1,-3,+1,+1,-3,-l) P-sheet topology 
similar to that of the Cu,Zn superoxide dismutase 
[23] is shown in fig.lC. 
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The proposed topology has allowed us to 
translate the primary and secondary structure of 
each functional domain of T, into a three- 
dimensional structure. This was accomplished by 
placing the homologous sequences and corre- 
sponding secondary structures of T, in positions 
identical to those found in the crystal structures of 
EF-Tu and Cu,Zn superoxide dismutase. A 
schematic model of the predicted tertiary structure 
of T, is shown in fig.2. The cu-helices and the ,8- 
strands of the molecule are designated as helices 
a-i and strands A-Q, respectively, starting from 
the amino-terminus. An essential rule of protein 
folding is to restrict the hydrophobic regions to the 
inside of the folded structure and to expose the 
hydrophilic segments to the solvent in order to 
maximize the stability of the system [24]. The 
hydropathy data shown in fig.lA suggest that 
strands B, C, E, F, J-N, P and Q are all relatively 
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hydrophobic. According to the model these are all 
buried within the molecule and are protected from 
the solvent. On the other hand, strands H, I, and 
G along with helices a, b and d-k are hydrophilic 
and are somewhat exposed in the model. Other 
features such as the protection of the P-sheet by a- 
helices and the hydrogen bonding between strands 
of anti-parallel P-sheets are all accounted for in the 
proposed model. 
2.3. The GTP-binding domain 
The central core of the guanine nucleotide- 
binding site consists of a hydrophobic twisted ,8- 
sheet made up of five parallel P-strands (strands K, 
A, L, M and N) and one anti-parallel &strand 
(strand J). These strands are connected by five 
hydrophilic a-helices which are partially exposed 
to the solvent. The nucleotide-binding site is 
situated at the carboxyl end of the P-sheet similar 
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to other nucleotide-binding proteins. [25], and the 
points of interaction of the nucleotide with the 
protein are located in four loops connecting ,0- 
strands with cu-helices. The phosphate-binding site 
is in the Rossmann fold containing residues 
Gly36-Ala-Gly-Glu-Ser-Glyd I. Magnesium ion 
binding occurs in a loop between strand K and 
helix f situated diametrically opposite the ,f3- 
phosphate of GDP and consists of the residues 
Asprgh-Val-Gly-Gly-Glnzoo. A salt bridge may be 
formed between the Mg2+ and the carboxyl group 
of Aspi96. The GDP-binding pocket does not seem 
large enough to accommodate the additional y- 
phosphate when GTP is bound to the site, unless 
the loop is moved to widen it. This movement 
could easily occur at the hinge region formed by 
Glyr98-Glyr99 and influence the position of strand 
K and helix f. It is conceivable that the movement 
of strand K and helix f could directly control the 
activation of PDE and dissociation of the 
transducin subunits from rhodopsin. 
2.4. The PDE activation domain 
This region is composed of a segment between 
the y-phosphate binding and the Mg2+ binding 
regions from Met49 to Va1r75 and is contained en- 
tirely within the 21 kDa tryptic fragment 
(Leui9-Arg204). The proposed Greek key barrel 
structure contains eight antiparallel P-strands 
(strands B, C, D, G, F, E, H and I) as shown in 
fig.2. The exact location of the site of interaction 
with PDE is still unclear. But since it involves 
protein-protein interactions, it is likely that it is 
located on the surface of the molecule. 
2.5. The receptor-binding domain 
This region is responsible for receiving the light 
activation signal from photolyzed rhodopsin which 
catalyzes the GTP exchange reaction. The TpY 
subunit is absolutely required for the binding of T, 
to rhodopsin [3]. Biochemical studies indicate that 
this domain involves the amino- and carboxyl- 
terminal peptides of T,. However, the exact loca- 
tions of the rhodopsin and Tpy interacting sites are 
still not clear. We presume that in the tertiary 
structure the two terminal regions are in close 
proximity, in a manner that provides the interac- 
ting sites for both rhodopsin and TflY binding. The 
amino-terminal 2 kDa peptide, helix a, is an ex- 
tremely hydrophilic a-helical structure. We suggest 
that the conformation of helix a may play an im- 
portant role in regulating the interaction of 
transducin with rhodopsin. A careful examination 
of the organization of the charged and the 
hydrophobic residues on helix a (fig.3) reveals an 
interesting feature which may be functionally 
significant. A distinct hydrophobic groove com- 
posed of Ala,, His,,, Leurs, Leuls, Ala23 and Ala2, 
can be identified on one side of the helical struc- 
ture. Surrounding this groove are charged residues 
of lysine, arginine, aspartate, and glutamate which 
are arranged in an alternating charge-pair fashion. 
Such an arrangement can allow a small rotation 
about the helical axis to turn the hydrophobic 
groove away from the protein surface and replace 
it with an extremely hydrophilic surface. An alter- 
nation of hydrophobic and charged residues on the 
interacting surface could be the molecular basis for 
I 
2wA 
i 
~lS.SA - 
Fig.3. Helical net representation of helix a of T,. The 
amino-terminal helix a of T, is presented as an a-helical 
net. Uncharged residues are represented by open circles, 
basic and acidic residues are represented by circles 
containing pluses and minuses, respectively. Hydropho- 
bic residues, Ala,, His,,, Leul5, Leu,9, Ala23 and Ala27, 
forming a hydrophobic groove on the helical structure 
are boxed. 
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the regulation of the association and dissociation 
properties of T, to rod outer segment membrane. 
Another region in this domain is composed of 
the carboxyl-terminal 5 kDa tryptic fragment con- 
sisting of alternating a-p-structural sequences. It 
is likely that the three,&-strands are arranged as a 
small anti-parallel &sheet (strands 0, P and Q) 
protected on both sides by cu-helices as depicted in 
fig.2. The pertussis toxin-catalyzed ADP- 
ribosylation of the Cys347 is greatly enhanced in the 
presence of the Tpy subunit and the cleavage of the 
amino-terminal peptide of T, reduces the Tpy 
enhancement on ADP-ribosylation [26]. This sug- 
gests that the conformation in this region is sen- 
sitive to the binding of TB,_ Helix i connects 
directly to the carboxyl-end of the P-sheet in the 
nucleotide-binding domain with a Gly28s-Pro2s9- 
Asn2g0 hinge region which can easily serve to 
transmit information between these two domains. 
This proximity can explain the influence of photo- 
lyzed rhodopsin and GTP exchange on each other 
and on the association and dissocation of the 
transducin-rhodopsin complex. 
3. MECHANISM OF ACTION 
The primary motivation for constructing a struc- 
tural model for T, was to provide a molecular 
mechanism for its coupling action. From the pro- 
posed model one can envision the rhodopsin- 
binding site of transducin as being composed of 
regions from both the T, and TB? subunits. Helix 
a, at the amino-terminal of T, has been suggested 
to be essential for the interaction with rhodopsin. 
As TD,, associates with the carboxyl-terminal region 
of To, helix a may be anchored with the TB~ 
subunit to form the rhodopsin-binding site. Under 
these conditions, the transducin molecule is 
associated with the rhodopsin membrane and is 
available for activation by photolyzed rhodopsin. 
In the absence of photolyzed rhodopsin, the 
guanine nucleotide-binding site is in a closed con- 
formation. Interaction with photolyzed rhodopsin 
opens up the nucleotide-binding site and allows 
rapid GTP/GDP exchange. Such an interaction 
must involve the transfer of information between 
the receptor-binding domain and the nucleotide- 
binding domain. In the closed conformation, helix 
i, located near the opening of the guanine 
nucleotide-binding pocket, is in a position to 
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hinder sterically the exchange of the bound 
nucleotide. Hence, it provides tight binding for the 
bound nucleotide with a dissociation constant 
smaller than IO-’ to lo-’ M [27]. The light- 
activated signal from the binding of photolyzed 
rhodopsin can be propagated to the nucleotide- 
binding site through the carboxyl-terminus which 
is complexed with rhodopsin/ToY. A conforma- 
tional change induced by the photolyzed rhodopsin 
is transmitted to helix i. A slight tilting of helix i 
results in opening of the nucleotide-binding pocket 
through a flexible hinge region (Gly2Ep-Pro289- 
Asn290). This open conformation enables 
nucleotide exchange to occur. 
Upon binding of GTP two major changes occur 
in the T,-GTP complex. First, it dissociates from 
photolyzed rhoddpsin and the Tpy subunit. Sec- 
ond, the PDE activation site of the Ta-GTP com- 
plex is exposed for interaction with the latent PDE. 
Based on the proposed model, when GTP binds to 
the guanine nucleotide-binding pocket additional 
space is needed to accommodate the y-phosphate 
of GTP. Strand K and helix f are pushed away 
from strand A and as a result, the groove between 
strand K and the nucleotide-binding domain is 
widened. The shift of the position of strand K also 
includes similar movement on the adjacent strand 
J. Such spatial rearrangement of strands K and J 
provides the molecular basis for the T, coupling 
function. As can be seen in fig.2, one end of strand 
K is linked directly to a flexible hinge region 
(G1y19s-G1y199) which is directly attached to helix f. 
The movement of strand K mechanically triggers 
the movement of helix f toward the PDE-binding 
domain. Hence, the conformational changes 
originating at the guanine nucleotide-binding do- 
main are now transmitted to the PDE-binding site 
and cause it to be exposed or assembled for PDE 
activation. The other ends of strands K and J are 
directed toward the rhodopsin/To,-binding do- 
main. The GTP-induced movement could disrupt 
the rhodopsin/To,-binding site that is formed by 
the amino-terminal helix a and the carboxyl- 
terminal peptide which may lead to the dissocia- 
tion of both the rhodopsin and the Tp, subunit 
from the T,-GTP complex. The flow of informa- 
tion between the three functional domains of T,, 
can be accomplished by shifting the spatial ar- 
rangement of a few p-strands and a-helices located 
in the interface of the three domains. 
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4. BIOCHEMICAL EVIDENCE 
4.1. Limited proteolysis 
It has been shown that tryptic cleavage at Argzm 
is protected by the binding of the non-hydrolyzable 
Gpp(NH)p. This site is located on the movable 
region of helix f. The movement of helix f induced 
by the binding of GTP to T, pushes helix f toward 
the PDE domain and as a result, Argz04 is buried 
inside the T, molecule and is not susceptible to 
tryptic digestion [8]. 
4.2. Chemical modification of T, 
Modification of a single sulfhydryl group has 
the opposite effect to modification of the lysine 
residues. The former only blocks the interaction 
with rhodopsin and Tar, whereas the latter inhibits 
the PDE activation and the GTP hydrolytic activi- 
ty [9,10]. These results can be interpreted in the 
light of the model. Since the coupling function of 
T, relies on the communication between the three 
domains, site-specific modification may block the 
interaction between only two of the three domains, 
hence inhibiting only part of the T, catalytic func- 
tions. Photoaffinity labeling of the GTP-binding 
sites with 8-azido-[a-32P]GTP showed that the 
guanine ring-binding site is linked to the 12 kDa 
tryptic fragment. However, using the [r-32P]- 
P,(4-azidoanilido)-P,-5 ’ -GTP as an affinity probe 
for the y-phosphate-binding site results in the for- 
mation of a covalent adduct with the 21 kDa tryp- 
tic fragment (Hingorani and Ho, unpublished). 
These results are in complete agreement with the 
proposed structure of the GTP-binding site of the 
T, molecule shown in fig.2. 
4.3. Comparison of the T, molecules of the rod 
and cone cells 
It is known that a similar but not identical 
transduction system exists in the cone photorecep- 
tor cells for color perception [28]. A distinct PDE 
which interacts with the cone T, has been sug- 
gested. The primary sequence homology between 
these two T, molecules is more than 85% [29] and 
the predicted secondary structures are the same, in- 
dicating that they may share a similar folding pat- 
tern. The guanine nucleotide-binding domain is 
essentially identical except for a variation on the 
suggested hinge region for the rod T, 
(Gly28s-Pro289-Asn290). The change in cone T, to 
Gly-Asn-Asn may have functional significance, 
such as differences in the affinity and exchange 
rates for guanine nucleotides. There are several 
variations in the proposed PDE activation domain, 
especially on helix d and the turn between strands 
H and I which may represent part of the PDE- 
interacting site. Indeed, the two variable locations 
are on the surface of the molecule and could easily 
interact with the PDE complex. The receptor- 
binding domain shows interesting variations. 
There are four additional residues (Glu-Leu-Ala- 
Lys) on helix a of cone T,. However, the 
hydrophobic groove as well as the charge-pair 
characteristic surrounding the groove remains un- 
changed. This observation implies that in spite of 
the added residues the nature of the interaction of 
cone T with color rhodopsin remains the same. It 
has been suggested that both T, molecules use the 
same To subunit as their modulator indicating that 
the To interacting sites are similar. The carboxyl- 
ends of the two T, molecules are identical. These 
comparisons provide additional support for the 
proposed model. 
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